☆ 4.6 Letter

Interleukin-1 blockade with anakinra in acute leukaemia patients with severe COVID-19 pneumonia appears safe and may result in clinical improvement

BRITISH JOURNAL OF HAEMATOLOGY (2020)

期刊

BRITISH JOURNAL OF HAEMATOLOGY

卷 190, 期 2, 页码 E80-E83

出版社

WILEY

DOI: 10.1111/bjh.16873

关键词

haemophagocytic syndrome; acute leukaemia; infection; immunotherapy

类别

Hematology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Medicine, General & Internal

Acute myeloid leukaemia

Courtney D. Dinardo, Harry P. Erba, Sylvie D. Freeman, Andrew H. Wei

Summary: Progress in acute myeloid leukaemia treatment has seen significant improvements in scientific understanding, prognostication tools, risk assessments, and incorporation of measurable residual disease into risk assessments. Recent updates in classification and recommendations by organizations such as WHO, ICC, and European LeukemiaNet have provided enhanced guidance for prognostic stratification and treatment response assessment. There have also been advancements in treatment options, leading to improved outcomes for both newly diagnosed and relapsed patients.

LANCET (2023)

添加到收藏夹

Review Rheumatology

Haemophagocytic syndrome and COVID-19

Soledad Retamozo, Pilar Brito-Zeron, Antoni Siso-Almirall, Alejandra Flores-Chavez, Maria-Jose Soto-Cardenas, Manuel Ramos-Casals

Summary: HLH is a hyperferritinaemic hyperinflammatory syndrome characterized by decreased interferon gamma production and activated NK phenotype. Viruses are closely linked to the development of HLH, and the break of tolerance to self-antigens is considered a critical mechanism in immune-mediated conditions triggered by viral infections.

CLINICAL RHEUMATOLOGY (2021)

添加到收藏夹

Article Mathematics, Applied

CAR T cell therapy in B-cell acute lymphoblastic leukaemia: Insights from mathematical models

Odelaisy Leon-Triana, Soukaina Sabir, Gabriel F. Calvo, Juan Belmonte-Beitia, Salvador Chulian, Alvaro Martinez-Rubio, Maria Rosa, Antonio Perez-Martinez, Manuel Ramirez-Orellana, Victor M. Perez-Garcia

Summary: Immunotherapies, particularly the use of CAR T cells to treat B-cell malignancies, have shown significant success in targeting cancer cells. A mathematical model describing the time response of leukaemias to CAR T cell injection accounts for various biological processes and predicts the dynamics of different compartments post-injection, emphasizing the potential role of competition between leukaemic and CAR T cells in cancer relapses.

COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Two Ways of Targeting a CD19 Positive Relapse of Acute Lymphoblastic Leukaemia after Anti-CD19 CAR-T Cells

Audrey Grain, Jocelyn Ollier, Thierry Guillaume, Patrice Chevallier, Baptiste Le Calvez, Marion Eveillard, Beatrice Clemenceau

Summary: This study explores the immunophenotyping and lysis sensitivity of CD19(+) relapses after anti-CD19 CAR-T cells and proposes different therapeutic options. The results show that CD19(+) relapses remain sensitive to cell lysis mediated by T-cell effectors. A broad immunophenotype analysis may provide new therapies for controlling high-risk ALL after immunotherapy.

BIOMEDICINES (2023)

添加到收藏夹

Article Hematology

Hyperinflammatory syndrome resembling haemophagocytic lymphohistiocytosis following axicabtagene ciloleucel and brexucabtagene autoleucel

Timothy J. Porter, Ana Lazarevic, Jamie E. Ziggas, Ephraim Fuchs, Kiryoung Kim, Helen Byrnes, Leo Luznik, Javier Bolanos-Meade, Syed Abbas Ali, Nirali N. Shah, Nina Wagner-Johnston, Tania Jain

Summary: CAR-HLH, a type of haemophagocytic lymphohistiocytosis-like toxicity that occurs following CAR-T cell therapy, is described in three patients in this report. Prompt recognition and initiation of potentially life-saving treatment for CAR-HLH is crucial.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

添加到收藏夹

Article Hematology

Blinatumomab as bridging therapy in paediatric B-cell acute lymphoblastic leukaemia complicated by invasive fungal disease

Daniel K. Yeoh, Christopher C. Blyth, Rishi S. Kotecha

Summary: Invasive fungal disease (IFD) is a challenging complication of paediatric acute leukaemia treatment. Guidelines recommend withholding chemotherapy to promote immune recovery, but this increases the risk of relapse. Blinatumomab, a new treatment option, shows promise in reducing toxicity.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

A Direct Comparison, and Prioritisation, of the Immunotherapeutic Targets Expressed by Adult and Paediatric Acute Myeloid Leukaemia Cells: A Systematic Review and Meta-Analysis

Vanessa S. Morris, Hanya Ghazi, Daniel M. Fletcher, Barbara-ann Guinn

Summary: Acute myeloid leukaemia (AML) is a disease characterized by an accumulation of immature cells in the bone marrow and peripheral blood. The study found that paediatric and adult AML patients share many of the same immunotherapy targets, including WT1, NRAS, IDH1 and TP53. Reusing immunotherapy drugs across age boundaries may improve the survival rates of AML patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Oncology

Leukaemia and lockdown: The delayed infection model of childhood acute lymphoblastic leukaemia and the COVID-19 pandemic

Katy Lillie

Summary: Acute lymphoblastic leukaemia is the most common type of leukaemia in children, and the prevailing hypothesis regarding its pathogenesis involves an abnormal immune response to common infections. The COVID-19 pandemic may have an impact on the infection hypothesis of childhood ALL.

PEDIATRIC BLOOD & CANCER (2021)

添加到收藏夹

Article Hematology

Identification of seasonal variation in the diagnosis of acute myeloid leukaemia: a population-based study

Fernando Sanchez-Vizcaino, Carmen Tamayo, Fernando Ramos, Daniel Lainez-Gonzalez, Juana Serrano-Lopez, Raquel Barba, Maria Dolores Martin, Pilar Llamas, Juan Manuel Alonso-Dominguez

Summary: This study found a clear seasonal pattern in the diagnosis of acute myeloid leukemia (AML) in the Spanish population. The incidence rates of AML showed an upward long-term trend, with January having the highest rate. This suggests that seasonal factors play a significant role in the development and proliferation of AML and presents opportunities for prevention.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

添加到收藏夹

Review Pediatrics

Genetics and pathophysiology of haemophagocytic lymphohistiocytosis

Marie Meeths, Yenan T. Bryceson

Summary: HLH is a life-threatening hyperinflammatory syndrome with genetic predisposition and associations with variants in genes related to metabolism or immunity. Molecular insights have provided fundamental knowledge of the immune system, deepening our understanding of hyperinflammatory diseases and highlighting new treatment strategies.

ACTA PAEDIATRICA (2021)

添加到收藏夹

Article Hematology

Epidemiology of haemophagocytic lymphohistiocytosis at the population level in Germany

David Kuron, Jakob Christoph Voran, Friedrich Alexander von Samson-Himmelstjerna, Claudia Baldus, Ulrich Kunzendorf, Kevin Schulte, Benedikt Kolbrink

Summary: By retrospectively analyzing German HLH patients, it was found that the incidence and related mortality of HLH have significantly increased, surpassing previous expectations.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

m6A RNA methylation regulators predict prognosis and indicate characteristics of tumour microenvironment infiltration in acute myeloid leukaemia

Xinai Liao, Ling Chen, Jingru Liu, Haoran Hu, Diyu Hou, Ruolan You, Xiaoting Wang, Huifang Huang

Summary: Patients with AML have poor prognoses due to heterogeneity and complex tumor microenvironment. This study analyzed the m(6)A modification features of 177 AML patients and identified three distinct m(6)A modification patterns related to biological functions, TME characteristics, and clinical outcomes. A risk score based on six m(6)A regulators was constructed and validated as an independent prognostic factor for AML. Four m(6)A regulators were found to be associated with AML survival and immune checkpoint inhibitor treatments. Understanding the m(6)A modification pattern can enhance our knowledge of AML and aid in the development of prognosis indicators and immunotherapeutic strategies.

EPIGENETICS (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity?

Annalisa Marcuzzi, Erika Rimondi, Elisabetta Melloni, Floriana Zennaro, Aurelio Sonzogni, Sara Leo, Natalia Maximova

Summary: Early post-transplant is critical for successful hematopoietic stem cell transplantation. New viral infections and inefficient reconstitution of the immune system are major risks. Traditional pharmacological treatments have limitations, while adoptive cell therapy can restore immune response to infectious agents.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Medicine, Research & Experimental

B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemia

Shuangshuang Fan, Tian Wang, Fengtao You, Tingting Zhang, Yafen Li, Cheng Ji, Zhichao Han, Binjie Sheng, Xiaochen Zhai, Gangli An, Huimin Meng, Lin Yang

Summary: This study constructed a CAR-T cell targeting B7-H3 and in vitro, B7-H3-CAR-T cells were co-cultured with six AML cell lines expressing different levels of B7-H3. The results showed that B7-H3-CAR-T cells had cytotoxic effects on B7-H3-positive AML tumor cells and effectively cleared B7-H3-expressing AML cell lines. In vivo experiments demonstrated that B7-H3-CAR-T cells significantly inhibited tumor cell growth in an AML mouse model and prolonged mouse survival compared to controls.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2023)

添加到收藏夹

Article Oncology

Childcare attendance and risk of childhood acute lymphoblastic leukaemia: A register study based on the Danish childcare database

Signe Holst Soegaard, Klaus Rostgaard, Mads Kamper-Jorgensen, Kjeld Schmiegelow, Henrik Hjalgrim

Summary: A study in Denmark found that there is no significant association between childcare attendance before age 2 and childhood acute lymphoblastic leukaemia (ALL). Previous studies suggested that childcare may help protect against ALL, but this study's findings did not support that.

INTERNATIONAL JOURNAL OF CANCER (2023)

添加到收藏夹

Article Hematology

Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy

Thomas A. Fox, Ethan Troy-Barnes, Amy A. Kirkwood, Wei Yee Chan, James W. Day, Selina J. Chavda, Emil A. Kumar, Kate David, Oliver Tomkins, Emilie Sanchez, Marie Scully, Asim Khwaja, Jonathan Lambert, Mervyn Singer, Claire Roddie, Emma C. Morris, Kwee L. Yong, Kirsty J. Thomson, Kirit M. Ardeshna

BRITISH JOURNAL OF HAEMATOLOGY (2020)

添加到收藏夹

Review Hematology

Gene therapy for primary immunodeficiencies

Thomas A. Fox, Claire Booth

Summary: Primary immunodeficiencies (PIDs) are rare inherited disorders of the immune system that often require allogeneic haematopoietic stem cell transplantation therapy. Autologous haematopoietic stem cell gene therapy has the potential to correct genetic defects without the risks associated with allogeneic approaches, but may still carry some risks.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Letter Hematology

Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies

Thomas A. Fox, Amy A. Kirkwood, Louise Enfield, Maeve O'Reilly, Suzanne Arulogun, Shirley D'Sa, Jenny O'Nions, Janki Kavi, Evan Vitsaras, William Townsend, Siobhan O. Burns, Satyen H. Gohil, Kate Cwynarski, Kirsty J. Thomson, Mahdad Noursadeghi, Robert S. Heyderman, Tommy Rampling, Kirit M. Ardeshna, Laura E. McCoy, Emma C. Morris

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Article Oncology

Gilteritinib monotherapy as a transplant bridging option for high risk FLT3-mutated AML with t(6;9)(p23;q34.1);DEK-NUP214 in morphological but not cytogenetic or molecular remission following standard induction chemotherapy

James W. Day, Thomas A. Fox, Rajeev Gupta, Asim Khwaja, Andrew J. Wilson, Panagiotis Kottaridis

Summary: This case provides supporting evidence for the use of single agent gilteritinib in high-risk primary refractory FLT3-mutated AML with t(6;9) prior to transplantation.

LEUKEMIA RESEARCH REPORTS (2022)

添加到收藏夹

Article Immunology

Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood

James W. Day, Reem Elfeky, Bethany Nicholson, Rupert Goodman, Rachel Pearce, Thomas A. Fox, Austen Worth, Claire Booth, Paul Veys, Ben Carpenter, Rachael Hough, H. Bobby Gaspar, Penny Titman, Deborah Ridout, Sarita Workman, Fernando Hernandes, Kit Sandford, Arian Laurence, Mari Campbell, Siobhan O. Burns, Emma C. Morris

Summary: This study aims to assess medical complications and factors influencing long-term outcomes in adult patients with inborn errors of immunity (IEI) following allogeneic hematopoietic stem cell transplant (HSCT). The results showed that while most patients had excellent immune reconstitution and low transplant-related complications, late-onset complications were common and associated with mixed chimerism.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Treatment and outcome of autoimmune hepatitis: Audit of 28 UK centres

Victoria Gordon, Ratul Adhikary, Victoria Appleby, Debasish Das, James Day, Toby Delahooke, Selena Dixon, David Elphick, Claire Hardie, Michael A. Heneghan, Barbara Hoeroldt, Patricia Hooper, John Hutchinson, Rebecca Jones, Faisal Khan, Guruprasad P. Aithal, Jane Metcalf, Alick Nkhoma, Stavroula Pelitari, Martin Prince, Annell Prosser, Vinay Sathyanarayana, Sushma Saksena, Deven Vani, Andrew Yeoman, George Abouda, Andrew Nelson, Dermot Gleeson

Summary: This study analyzed the treatment and outcomes of 1267 patients with autoimmune hepatitis (AIH) in 28 UK hospitals. It found that patients who were untreated with steroids, received higher prednisolone doses, and did not receive a steroid-sparing agent (SSA) had higher death/transplant rates.

LIVER INTERNATIONAL (2022)

添加到收藏夹

Article Immunology

Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity

Bethany Nicholson, Rupert Goodman, James Day, Austen Worth, Ben Carpenter, Kit Sandford, Emma C. Morris, Siobhan O. Burns, Deborah Ridout, Penny Titman, Mari Campbell

Summary: This study aimed to investigate the long-term social and psychological outcomes for adults who underwent HSCT for IEI during childhood. The findings showed that patients reported better physical health-related quality of life than the general population norm, but worse than matched controls. Patients also reported higher levels of anxiety and lower mood than the general population. More research is needed to establish screening protocols and interventions to maximize holistic outcomes.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Article Hematology

Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity

Morgane Cheminant, Thomas A. Fox, Mickael Alligon, Olivier Bouaziz, Benedicte Neven, Despina Moshous, Stephane Blanche, Aurelien Guffroy, Claire Fieschi, Marion Malphettes, Nicolas Schleinitz, Antoinette Perlat, Jean-Francois Viallard, Nathalie Dhedin, Francoise Sarrot-Reynauld, Isabelle Durieu, Sebastien Humbert, Fanny Fouyssac, Vincent Barlogis, Benjamin Carpenter, Rachael Hough, Arian Laurence, Ambroise Marcais, Ronjon Chakraverty, Olivier Hermine, Alain Fischer, Siobhan O. Burns, Nizar Mahlaoui, Emma C. Morris, Felipe Suarez

Summary: Allogeneic hematopoietic stem cell transplantation (alloSCT) is a curative treatment for severe inborn errors of immunity (IEIs). Recent data suggests that alloSCT is safe and effective in selected adult patients. However, questions remain regarding the indications and optimal timing of the transplant.

BLOOD (2023)

添加到收藏夹

Article Immunology

Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation

Alan Kennedy, Erin Waters, Behzad Rowshanravan, Claudia Hinze, Cayman Williams, Daniel Janman, Thomas A. Fox, Claire Booth, Anne M. Pesenacker, Neil Halliday, Blagoje Soskic, Satdip Kaur, Omar S. Qureshi, Emma C. Morris, Shinji Ikemizu, Christopher Paluch, Jiandong Huo, Simon J. Davis, Emmanuel Boucrot, Lucy S. K. Walker, David M. Sansom

Summary: CD28 and CTLA-4 play important roles in regulating T cell immunity. The study found that CTLA-4 captures ligands through transendocytosis, and CD80 leads to ubiquitination and degradation of CTLA-4, while CD86 allows CTLA-4 to detach and recycle back to the cell surface. Clinically relevant mutations disrupt CD86 transendocytosis and are associated with autoimmune diseases.

NATURE IMMUNOLOGY (2022)

添加到收藏夹

Article Cell Biology

Therapeutic gene editing of T cells to correct CTLA-4 insufficiency

Thomas Andrew Fox, Benjamin Christopher Houghton, Lina Petersone, Erin Waters, Natalie Mona Edner, Alex McKenna, Olivier Preham, Claudia Hinze, Cayman Williams, Adriana Silva de Albuquerque, Alan Kennedy, Anne Maria Pesenacker, Pietro Genovese, Lucy Sarah Kate Walker, Siobhan Oisin Burns, David Michael Sansom, Claire Booth, Emma Catherine Morris

Summary: A gene editing strategy was designed to insert the CTLA-4 cDNA into primary human T cells, restoring CTLA-4 expression and demonstrating the feasibility of using T cell gene therapy for CTLA-4 insufficiency.

SCIENCE TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Letter Biochemistry & Molecular Biology

Access to gene therapy for rare diseases when commercialization is not fit for purpose

Thomas Fox, Juan Bueren, Fabio Candotti, Alain Fischer, Alessandro Aiuti, Arjan Lankester, Michael AGORA Initiative, Michael Albert, Maria Ester Bernardo, Marina Cavazzana, Stephan Ehl, Benedicte Neven, Johan Prevot, Axel Schambach, Julian Sevilla, Adrian Thrasher, Rob Wynn, Claire Booth

NATURE MEDICINE (2023)

添加到收藏夹

Article Hematology

Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccination

Christopher L. Pinder, Dylan Jankovic, Thomas A. Fox, Amy Kirkwood, Louise Enfield, Aljawharah Alrubayyi, Emma Touizer, Rosemarie Ford, Rachael Pocock, Jin-Sup Shin, Joseph Ziegler, Kirsty J. Thomson, Kirit M. Ardeshna, Dimitra Peppa, Laura E. McCoy, Emma C. Morris

Summary: Patients with B-cell malignancies have poor responses to COVID-19 vaccination, as shown by low seroconversion rates and neutralizing responses after the first and second doses. However, a third and fourth dose significantly improved the seropositivity and neutralization rates. The T-cell response remained largely intact throughout the vaccination course, with a boost in measurable response after the second dose.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.